Senior insider sale
CRISPR THERAPEUTICS AG — senior position signals high conviction
$720.4K
14.51K shares
What this filing means
GEORGE SIMEON plans to sell 14.51K shares of CRISPR THERAPEUTICS AG valued at approximately $720.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/14/2026ACC: 0001950047-26-010218
14.51K
Shares to sell
$720.4K
Approx. market value
14.51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/14/2026
14.51KTotal acquired14.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/14/2026 | Stock Option Exercise Cash | 14.51K | — |
| Total | 14.51K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
14.51K
Market value
$720.4K
10/14/2026
Total
Units
14.51K
Value
$720.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/14/2026 | 14.51K | $720.4K | NASDAQ | Planned |
| Total | 14.51K | $720.4K | ||